The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final analysis of dose-finding and single-arm confirmatory study (phase I/II study) of definitive chemoradiotherapy (dCRT) with S-1/mitomycin-C (MMC) in patients (pts) with clinical (c) Stage II/III squamous cell carcinoma of the anal canal (SCCA): JCOG0903.
 
Yoshinori Ito
No Relationships to Disclose
 
Tetsuya Hamaguchi
Honoraria - Bayer; Bristol-Myers Squibb Japan; Chugai Pharma; Fujifilm; Lilly; Merck Serono; Novartis; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Chugai Pharma (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Atsuo Takashima
Honoraria - Chugai Pharma; Lilly; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Research Funding - Eisai (Inst); Merck Sharp & Dohme (Inst); Ono Pharmaceutical (Inst); Sumitomo Group (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Junki Mizusawa
Honoraria - Chugai Pharma; Taiho Pharmaceutical
 
Yasuhiro Shimada
Honoraria - Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical
Research Funding - MSD K.K (Inst); Taiho Pharmaceutical (Inst)
 
Manabu Shiozawa
No Relationships to Disclose
 
Takeshi Kodaira
No Relationships to Disclose
 
Masayuki Ohue
No Relationships to Disclose
 
Makoto Kinouchi
No Relationships to Disclose
 
Kohei Murata
No Relationships to Disclose
 
Gen Iinuma
No Relationships to Disclose
 
Fumihiko Fujita
No Relationships to Disclose
 
Hirohisa Miura
No Relationships to Disclose
 
Fumio Ishida
No Relationships to Disclose
 
Yoshihisa Saida
No Relationships to Disclose
 
Takahisa Matsuda
No Relationships to Disclose
 
Hiroshi Katayama
No Relationships to Disclose
 
Haruhiko Fukuda
Honoraria - Chugai Pharma
 
Yukihide Kanemitsu
Honoraria - Chugai Pharma; Covidien; Ethicon; Intuitive Surgical
Consulting or Advisory Role - Covidien